Cost-Effectiveness of Scaling Up HCV Prevention and Treatment in the United States for People Who Inject Drugs

AIMS: To examine the cost-effectiveness of hepatitis C (HCV) treatment of people who inject drugs (PWID), combined with medication-assisted treatment (MAT) and syringe-service programs (SSP), to tackle the increasing HCV epidemic in the United States. DESIGN: HCV-transmission and disease progression...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Addiction
Auteurs principaux: Barbosa, Carolina, Fraser, Hannah, Hoerger, Thomas J., Leib, Alyssa, Havens, Jennifer R., Young, April, Kral, Alex, Page, Kimberly, Evans, Jennifer, Zibbell, Jon, Hariri, Susan, Vellozzi, Claudia, Nerlander, Lina, Ward, John W., Vickerman, Peter
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751348/
https://ncbi.nlm.nih.gov/pubmed/31307116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14731
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires